Blueberry Pediatrics

blueberrypediatrics.com →

-71%

est. 2Y upside i

HealthcareSeries A

24/7 pediatric clinic in every family's living room

Rank

#1753

Sector

Telehealth / Pediatric Care

Est. Liquidity

~4Y

Data Quality

Data: Medium

Blueberry Pediatrics operates in a rapidly expanding pediatric telehealth market, showing promising customer satisfaction and strategic partnerships.

Last updated: March 10, 2026

Bull (15%)+400%

Blueberry Pediatrics successfully expands its strategic partnerships and leverages its unique home medical kit and 24/7 access to capture significant market share in the rapidly growing pediatric telehealth sector. This drives revenue to over $37.5M by 2028, justifying a $375M+ valuation at a 10x multiple, representing a 400% upside from the current estimated valuation.

Base (40%)+80%

The company maintains its current growth trajectory, expanding customer adoption at a steady pace and benefiting from the overall pediatric telehealth market growth. Revenue reaches approximately $15M by 2028, leading to a valuation of around $135M, an 80% upside, as it continues to carve out a niche despite incumbent competition.

Bear (45%)-80%

Dominant incumbents like Teladoc Health and Amwell aggressively enter or expand their pediatric telehealth offerings, leading to intense pricing pressure and customer churn. Regulatory changes or issues with the home medical kit further hinder growth, causing revenue to stagnate or decline. A down round leads to a valuation of $15M, wiping out most common stock value given existing liquidation preferences.

Est. time to liquidity~4.0 years

Preference Stack Risk

moderate

Investors hold $9.45M in liquidation preferences ahead of common stock, representing 12.6% of the estimated current valuation.

Dilution Risk

high

As a Series A company, Blueberry Pediatrics will likely require additional funding rounds, which will lead to further dilution for existing equity holders.

Secondary Liquidity

none

There is no indication of active secondary markets or tender offers for a company at this stage.

Medical — 2 roles

Engineering — 1 role

View all 3 open roles at Blueberry Pediatrics →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Blueberry Pediatrics's data — designed to show you've done your homework.

  • 1

    “Given the significant market presence of incumbents like Teladoc Health and Amwell, how does Blueberry Pediatrics plan to sustain and expand its competitive moat beyond the home medical kit?”

  • 2

    “With an estimated $8.3M in annual revenue, what are the key growth levers and expansion strategies for Blueberry Pediatrics over the next 2-3 years to reach a valuation that provides meaningful returns for common shareholders?”

  • 3

    “Considering the Series A funding in 2022 and the current market conditions, what is the anticipated timeline and strategy for a liquidity event for employees holding equity, and how is the company addressing potential dilution risks in future funding rounds?”

Community

Valuation Sentiment

Our model estimates -71% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.